Cardinal Health Stock (NYSE:CAH)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$221.16

52W Range

$137.75 - $233.60

50D Avg

$202.78

200D Avg

$195.75

Market Cap

$52.43B

Avg Vol (3M)

$2.07M

Beta

0.53

Div Yield

$2.04 (0.91%)

CAH Company Profile


Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.

Show More

Industry

Medical - Distribution

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

57,700

IPO Date

Aug 04, 1983

Website

CAH Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceJun 25Jun 24Jun 23
Pharmaceutical Member$204.64B$210.02B-
Other Operating Segment$5.38B$4.51B-
GMPD$12.64B$12.38B-
Medical Member--$15.01B

Fiscal year ends in Jun 25 | Currency in USD

CAH Financial Summary


Jun 25Jun 24Jun 23
Revenue$222.58B$226.83B$205.01B
Operating Income$2.27B$1.24B$752.00M
Net Income$1.56B$852.00M$330.00M
EBITDA$2.79B$1.98B$1.44B
Basic EPS$6.48$3.48$1.26
Diluted EPS$6.45$3.45$1.26

Fiscal year ends in Jun 25 | Currency in USD

Latest Earnings Call Transcripts


Q3 26Apr 30, 26 | 12:00 AM
Q2 26Feb 05, 26 | 8:30 AM
Q1 26Oct 30, 25 | 8:30 AM

Peer Comparison


TickerCompany
HLNHaleon plc
RMDResMed Inc.
EWEdwards Lifesciences Corporation
CORCencora, Inc.
BDXBecton, Dickinson and Company
VEEVVeeva Systems Inc.
ARGXargenx SE
IQVIQVIA Holdings Inc.
AAgilent Technologies, Inc.
BRKRBruker Corporation